Daniel Petree
Director/Board Member at SUTRO BIOPHARMA, INC.
Net worth: 76 803 $ as of 2024-04-29
Network origin in Daniel Petree first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Stanford University
477
| College/University | Other Consumer Services | 477 |
The University of Michigan Law School
24
| College/University | Other Consumer Services | 24 |
| Public Company | Pharmaceuticals: Major | 22 | |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.
14
| Extinct | Biotechnology | 14 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
| Public Company | Medical Specialties | 9 | |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA.
8
| Extinct | Biotechnology | 8 |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Four Oaks Partners LLC
2
| Private Company | 2 | |
TSI Corp
1
| Extinct | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Petree via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal Sales & Marketing | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree | |
Thirona Bio, Inc.
 Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder Director/Board Member Founder Founder | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member Director/Board Member | |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Founder Corporate Officer/Principal | |
| EXPONENT, INC. | Engineering & Construction | Corporate Officer/Principal Director/Board Member | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Security Pacific Capital Markets Group, Inc.
 Security Pacific Capital Markets Group, Inc. Finance/Rental/LeasingFinance Part of Citigroup, Inc., Security Pacific Capital Markets Group, Inc. is a company that provides consumer lending services. The company is based in West Covina, CA. Security Pacific Capital Markets Group was acquired by Commercial Credit Co. from BankAmerica Corp. on July 31, 1997 for $1,600 million. | Finance/Rental/Leasing | Chairman Private Equity Investor | |
| George Mason University | College/University | Corporate Officer/Principal Masters Business Admin | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Innovative Decisions, Inc.
 Innovative Decisions, Inc. Miscellaneous Commercial ServicesCommercial Services Innovative Decisions, Inc. provides risk analysis, operations research, and systems engineering. It is an analytics consulting firm, which serving business and government clients and specializing in the disciplines of decision and risk analysis, operations research, and systems engineering. The company was founded by Joseph A. Tatman and Dennis M. Buede in 1997 and is headquartered in Vienna, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
| Micromet Inc. | Chairman Corporate Officer/Principal | ||
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The University of Chicago | College/University | Director/Board Member Corporate Officer/Principal | |
| HP INC. | Computer Processing Hardware | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERTEK GROUP PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Vitaphore Corp. | Chairman President | ||
| GILEAD SCIENCES, INC. | Biotechnology | Public Communications Contact Corporate Officer/Principal | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| IBM | Packaged Software | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ACTEL CORPORATION | Semiconductors | Founder Corporate Officer/Principal | |
| SUNPOWER CORPORATION | Engineering & Construction | Chairman Founder | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Chairman | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistics
International
| United States | 47 |
| Canada | 2 |
| Israel | 2 |
| Mauritius | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 17 |
| Commercial Services | 8 |
| Finance | 3 |
| Industrial Services | 3 |
Operational
| Director/Board Member | 520 |
| Corporate Officer/Principal | 211 |
| Chairman | 144 |
| Independent Dir/Board Member | 122 |
| Undergraduate Degree | 94 |
Most connected contacts
| Insiders | |
|---|---|
| David Hale | 54 |
| John P. Walker | 39 |
| Valerie Jarrett | 38 |
| George Hutton | 37 |
| John Freund | 37 |
| Thurman Rodgers | 33 |
| Ivor Royston | 30 |
| Gary Kurtzman | 30 |
| Dan Kisner | 29 |
| Kurt Richard Jaggers | 29 |
| Brad Mills Mills | 25 |
| David S. Lobel | 24 |
| Jean-Lou Chameau | 20 |
| Yan Hok Fan | 20 |
| Andrew Lanza | 19 |
- Stock Market
- Insiders
- Daniel Petree
- Company connections
